Literature DB >> 410361

Activity of netilmicin compared with those of gentamicin and tobramycin against enterobacteria and Pseudomonas aeruginosa.

P Chadwick, S Salmon, B Taylor.   

Abstract

The inhibitory activity of netilmicin against 500 isolates of gram-negative bacteria was compared with those of gentamicin and tobramycin. Netilmicin was considerably less active than tobramycin and slightly less inhibitory than gentamicin for Pseudomonas aeruginosa but was at least as active against Escherichia coli and Klebsiella pneumoniae as were the other two antibiotics. A few Klebsiella and Serratia isolates resistant to gentamicin and tobramycin were inhibited by netilmicin. All three antibiotics were strongly bactericidal for E. coli, K. pneumoniae and P. aeruginosa but had less lethal activity against the otherwise susceptible Serratia isolates tested. Some necessary precautions in reading minimal inhibitory concentrations on agar media are stressed, and some possible advantages of a 4-h bactericidal test, using a constant antibiotic concentration, are defined.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 410361      PMCID: PMC429909          DOI: 10.1128/AAC.12.3.301

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  Biochemical identification of hospital enterobacteria by replica agar plating.

Authors:  P Chadwick; G J Delisle; M Byer
Journal:  Can J Microbiol       Date:  1974-12       Impact factor: 2.419

2.  Susceptibility of 1,500 isolates of Pseudomonas aeruginosa to gentamicin, carbenicillin, colistin, and polymyxin B.

Authors:  I B Duncan
Journal:  Antimicrob Agents Chemother       Date:  1974-01       Impact factor: 5.191

3.  The activity of penicillin and eight cephalosporins on Neisseria gonorrhoeae.

Authors:  I Phillips; A King; C Warren; B Watts
Journal:  J Antimicrob Chemother       Date:  1976-03       Impact factor: 5.790

4.  In vitro study of netilmicin compared with other aminoglycosides.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

5.  In vitro comparison of netilmicin, a semisynthetic derivative of sisomicin, and four other aminoglycoside antibiotics.

Authors:  S A Kabins; C Nathan; S Cohen
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

6.  In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to netilmicin and selected aminoglycoside antibiotics.

Authors:  R D Meyer; L L Draus; K A Pasieczinik
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

7.  Activity of newer aminoglycosides and carbenicillin, alone and in combination, against gentamicin-resistant Pseudomonas aeruginosa.

Authors:  M I Marks; S Hammerberg; G Greenstone; B Silver
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

8.  Effect of medium composition on the apparent sensitivity of Pseudomonas aeruginosa to gentamicin.

Authors:  L P Garrod; P M Waterworth
Journal:  J Clin Pathol       Date:  1969-09       Impact factor: 3.411

  8 in total
  4 in total

1.  Assay of netilmicin, using enzyme immunoassay for gentamicin.

Authors:  T Larson; D N Gerding; L R Peterson; J H Eckfeldt
Journal:  Antimicrob Agents Chemother       Date:  1982-03       Impact factor: 5.191

2.  Therapeutic experience with netilmicin.

Authors:  P Chadwick; A W Bruce; T D Cooke; G J Hardy
Journal:  Can Med Assoc J       Date:  1978-11-18       Impact factor: 8.262

3.  Comparative susceptibilities of clinical isolates of Serratia marcescens to newer cephalosporins, alone and in combination with various aminoglycosides.

Authors:  S M Markowitz; D J Sibilla
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

4.  Pharmacokinetic assessment of netilmicin in newborns and older children.

Authors:  T Bergan; H Michalsen
Journal:  Infection       Date:  1982       Impact factor: 3.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.